Page last updated: 2024-09-03

mk 0663 and Angiogenesis, Pathologic

mk 0663 has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ghanghas, P; Jain, S; Rana, C; Sanyal, SN	1
Nadda, N; Sanyal, SN; Setia, S; Vaish, V	1

Other Studies

2 other study(ies) available for mk 0663 and Angiogenesis, Pathologic

Article	Year
Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2016, Volume: 35, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Celecoxib; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Neovascularization, Pathologic; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones	2016
Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Chemokines; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Gene Expression Regulation, Neoplastic; Lung; Lung Neoplasms; Macrophages, Alveolar; Matrix Metalloproteinases, Secreted; Membrane Fluidity; Neovascularization, Pathologic; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Tumor Burden	2012

Article

Year

Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs.

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2016, Volume: 35, Issue:3

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Celecoxib; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Neovascularization, Pathologic; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones

2016

Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:6

Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Chemokines; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Gene Expression Regulation, Neoplastic; Lung; Lung Neoplasms; Macrophages, Alveolar; Matrix Metalloproteinases, Secreted; Membrane Fluidity; Neovascularization, Pathologic; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Tumor Burden

2012